Patents by Inventor Mary Patricia Corr

Mary Patricia Corr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230365570
    Abstract: The disclosure relates to 1H-pyrazolo[3,4-d]pyrimidin-4-amine compounds and 1-nitro-5-amido-disubstituted furan compounds, or a pharmaceutically acceptable salt thereof, and methods for their use in treating, among other conditions, inflammatory diseases or an autoimmune diseases.
    Type: Application
    Filed: October 5, 2021
    Publication date: November 16, 2023
    Inventors: Dennis A. Carson, Tomoko Hayashi, Mary Patricia Corr, Howard B. cottam, Tadashi Hosoya, Nikunj Shukla
  • Publication number: 20220152188
    Abstract: A method to enhance an immune response in a mammal, and a composition comprising liposomes, a TLR4 agonist and a TLR7 agonist, are provided.
    Type: Application
    Filed: March 13, 2020
    Publication date: May 19, 2022
    Inventors: Dennis A. Carson, Howard B. Cottam, Tomoko Hayashi, Mary Patricia Corr
  • Publication number: 20210380546
    Abstract: Compounds useful as an adjuvant, e.g., formulas (I)-(VI) and uses thereof, for example, with immunogenic moieties or other adjuvants, are provided.
    Type: Application
    Filed: October 22, 2019
    Publication date: December 9, 2021
    Inventors: Dennis Carson, Mary Patricia Corr, Howard B. Cottam, Tomoko Hayashi, Nikunj Shukla
  • Patent number: 7816352
    Abstract: The present invention provides compounds that act as selective agents to protect against unintentional cell death or tissue damage and can relieve side effects of cancer treatment such as, for example, oral mucositis, hair loss, diarrhea due to damage to the gastrointestinal epithelium, and myelosuppression. In addition, these compounds can be used to prevent premature cell death when the cell death is caused by signals from damaged cells, for example, signals generated as the result of a traumatic incident or an ischemic episode.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: October 19, 2010
    Assignee: The Regents of The University of California
    Inventors: Dennis A. Carson, Howard B. Cottam, Sylvie Barchéchath, Mary Patricia Corr
  • Publication number: 20080280903
    Abstract: The present invention provides compounds that act as selective agents to protect against unintentional cell death or tissue damage and can relieve side effects of cancer treatment such as, for example, oral mucositis, hair loss, diarrhea due to damage to the gastrointestinal epithelium, and myelosuppression. In addition, these compounds can be used to prevent premature cell death when the cell death is caused by signals from damaged cells, for example, signals generated as the result of a traumatic incident or an ischemic episode.
    Type: Application
    Filed: March 10, 2006
    Publication date: November 13, 2008
    Inventors: Dennis A. Carson, Howard B. Cottam, Sylvie Barchechath, Mary Patricia Corr
  • Patent number: 7211599
    Abstract: The present invention provides a therapeutic method to treat non-malignant diseases characterized by the excessive tissue growth, e.g., hyperplastic diseases, comprising administering to a mammal (e.g.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: May 1, 2007
    Assignees: The Regents of the University of California, Cephalon, Inc.
    Inventors: Dennis A. Carson, Lorenzo M. Leoni, Mary Patricia Corr
  • Publication number: 20040127431
    Abstract: The present invention provides a therapeutic method to treat non-malignant diseases characterized by the excessive tissue growth, e.g., hyperplastic diseases, comprising administering to a mammal (e.g.
    Type: Application
    Filed: September 19, 2003
    Publication date: July 1, 2004
    Inventors: Dennis A. Carson, Lorenzo M. Leoni, Mary Patricia Corr